Hyperuricemia as a component of cardiorenal syndrome

Hyperuricemia as a component of cardiorenal syndrome

The role of hyperuricemia as a cardiovascular and renal risk factor and approaches to its correction are discussed.

Bibliographic Details
Main Authors:	Nikolay Alekseevich Mukhin, Viktor Viktorovich Fomin, M V Lebedeva, N A Mukhin, V V Fomin
Format:	Article
Language:	Russian
Published:	"Consilium Medicum" Publishing house 2011-06-01
Series:	Терапевтический архив
Subjects:	hyperuricemia chronic kidney disease cardiovascular complications cardio-renal syndrome
Online Access:	https://ter-arkhiv.ru/0040-3660/article/view/30830

Similar Items

Hyperuricemia and Hypertension: Links and Risks
by: Stewart DJ, et al.
Published: (2019-12-01)

FEBUXOSTAT FOR TREATMENT OF CHRONIC HYPERURICEMIA IN GOUT PATIENTS
by: M. S. Petrova, et al.
Published: (2017-11-01)

Chronic kidney disease and atrial fibrillation as components of the cardiorenal continuum
by: N A Mukhin, et al.
Published: (2016-06-01)

Hyperuricemia and the problem of chronic kidney disease
by: A V Shcherbak, et al.
Published: (2013-06-01)

Biomarkers in Cardiorenal Syndrome
by: Giovanni Goffredo, et al.
Published: (2021-07-01)

Hyperuricemia — an independent factor for the progression of chronic kidney disease
by: M.D. Tronko, et al.
Published: (2017-04-01)

Hyperuricemia, gout and high cardiovascular risk - how to manage them in clinical practice
by: V V Fomin, et al.
Published: (2019-12-01)

Hyperuricemia, a Non-Independent Component of Metabolic Syndrome, Only Predicts Renal Outcome in Chronic Kidney Disease Patients without Metabolic Syndrome or Diabetes
by: Sheng-Wen Niu, et al.
Published: (2022-07-01)

Cardio-Renal Syndrome Type 4: The Correlation Between Cardiorenal Ultrasound Parameters
by: Silvia Lai, et al.
Published: (2016-09-01)

Association between hyperuricemia and hypertension in chronic kidney disease
by: QIAN Ying, MA Xiaobo, GAO Chenni, ZHANG Chunli, MA Jun, ZHANG Wen, CHEN Xiaonong
Published: (2023-04-01)

IS HYPERURICEMIA A COMPONENT OF THE METABOLIC SYNDROME?
by: P. H. Janashya, et al.
Published: (2001-02-01)

Molecular Biological and Clinical Understanding of the Pathophysiology and Treatments of Hyperuricemia and Its Association with Metabolic Syndrome, Cardiovascular Diseases and Chronic Kidney Disease
by: Hidekatsu Yanai, et al.
Published: (2021-08-01)

Role of asymptomatic hyperuricemia in the progression of chronic kidney disease and cardiovascular disease
by: Yousuf Waheed, et al.
Published: (2021-11-01)

Hyperuricemia and prognosis in chronic kidney disease
by: D.D. Ivanov, et al.
Published: (2017-08-01)

Hyperuricemia and its related histopathological features on renal biopsy
by: Shulei Fan, et al.
Published: (2019-03-01)

Left ventricular function in patients with cardiorenal pathology and chronic renal failure
by: M. M. Dudar, et al.
Published: (2006-06-01)

Cardiorenal syndrome in ischemic renal disease (atherosclerotic renovascular hypertension)
by: N A Mukhin, et al.
Published: (2008-08-01)

Ultrasonographic findings in patients with chronic kidney disease with asymptomatic hyperuricemia
by: Nashwa Ismail Hashaad, et al.
Published: (2022-10-01)

Hyperuricemia in predialysis chronic kidney disease patients in Southern Nigeria
by: Oluseyi A Adejumo, et al.
Published: (2016-01-01)

Cardiorenal syndrome and vitamin D receptor activation in chronic kidney disease
by: Sirous Darabian, et al.
Published: (2012-03-01)

Erythropoietin in Cardiorenal Anemia Syndrome
by: Emir Fazlibegović, et al.
Published: (2008-11-01)

Asymptomatic hyperuricemia: secret relationships, invisible effects and potential complications
by: I. Yu. Golovach, et al.
Published: (2021-01-01)

The Efficacy and Safety of Dotinurad on Uric Acid and Renal Function in Patients with Hyperuricemia and Advanced Chronic Kidney Disease: A Single Center, Retrospective Analysis
by: Yanai K, et al.
Published: (2023-11-01)

El síndrome anemia cardio-renal The cardiorenal anemia syndrome
by: Carlos Ramos Emperador, et al.
Published: (2010-12-01)

Treating Hyperuricemia: The Last Word Hasn’t Been Said Yet
by: Elisa Russo, et al.
Published: (2021-02-01)

Hyperuricemia as a Risk Factor in Hypertension among Patients with Very High Cardiovascular Risk
by: Paweł Muszyński, et al.
Published: (2023-09-01)

Heart failure and cardiorenal syndrome: a case report
by: Valentina Zilioli, et al.
Published: (2011-03-01)

The influence of selective vitamin D receptor activator paricalcitol on cardiovascular system and cardiorenal protection
by: Duplancic D, et al.
Published: (2013-02-01)

New insight into the management of renal excretion and hyperuricemia: Potential therapeutic strategies with natural bioactive compounds
by: Bendong Yang, et al.
Published: (2022-11-01)

Hyperuricemia is a risk factor for the progression to end-stage renal disease in minimal change disease
by: Su Hyun Song, et al.
Published: (2021-09-01)

Association of hyperuricemia and serum uric acid lowering therapy with mortality in hemodialysis patients
by: Benjamin Rohn, et al.
Published: (2020-01-01)

Ischemic disease of the kidneys
by: N A Mukhin, et al.
Published: (2003-06-01)

Physicians' perceptions of asymptomatic hyperuricemia in patients with chronic kidney disease: A questionnaire survey
by: Ran-hui Cha, et al.
Published: (2019-09-01)

Chronic progressive nephropathies and modern lifestyle
by: N A Mukhin, et al.
Published: (2004-09-01)

Interrelationships between hyperuricemia, metabolic syndrome and chronic kidney disease in patients with diabetes mellitus
by: Adriana BAIDOG, et al.
Published: (2020-09-01)

Editorial: Contribution of Uremic Compounds to Cardiorenal Syndrome Development
by: Marcela Sorelli Carneiro-Ramos, et al.
Published: (2022-05-01)

The unanswered Questions in Hyperuricemia: is it a cause of chronic kidney disease, a compensation mechanism, a coincidence, a consequence of disease or concurrent phenomenon?
by: M. Kolesnyk
Published: (2018-12-01)

Renal effects of uric acid: hyperuricemia and hypouricemia
by: Jung Hwan Park, et al.
Published: (2020-11-01)

Hyperuricemia and Associated Factors in Children with Chronic Kidney Disease: A Cross-Sectional Study
by: Jie Xu, et al.
Published: (2021-12-01)

Efficacy and safety of urate-lowering agents in asymptomatic hyperuricemia: systematic review and network meta-analysis of randomized controlled trials
by: Tunlanut Sapankaew, et al.
Published: (2022-06-01)